The pharma has four locations in Ireland, employing more than 1,000 professionals.
Japanese pharmaceutical company Takeda has announced plans to cut 4,500 people from its globally dispersed workforce, as a means of restructuring and reducing costs. Reportedly the cuts will start in early July and could extend to December 2027.
According to a recent investor presentation, the company’s restructuring plans will include consolidating its departments for efficiency, cutting management layers and automating operations, all in the name of generating the necessary funds to support upcoming drug launches.
Current hiring plans will not be impacted however, as Takeda intends to fill 2,200 vacant roles. Some of which will go to internal candidates. With more than 50,000 workers worldwide, in more than 80 global locations, it is unclear which regions will be most impacted.
It is unknown how the cuts might affect Ireland. The pharmaceutical company has had a presence in the country since 1997 and has four locations. In Dublin there are facilities at Citywest, Grange Castle and Baggot Street. There is also a premises in Bray, Wicklow.
The Bray facility was previously chosen as Takeda’s first European OSD facility, allowing expansion into global markets and in 2004 Takeda chose Grange Castle as its first active pharmaceutical ingredient facility outside of Japan. Currently, the company employs more than 1,000 people in Ireland.
SiliconRepublic.com has reached out to Takeda regarding how the layoffs might impact employees based in Ireland.
Earlier this week coding platform GitLab announced plans to cut an undisclosed number of jobs, with additional plans to reduce its global operational footprint by up to 30pc. Carmaker GM also announced layoffs, with around 30 Ireland-based employees expected to be affected in the layoffs.
Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.